Insider · CIK 0002079859
Peter Klaus Marschel
Files at DCOY (Salarius Pharmaceuticals, Inc.). First filing -, latest -.
Peter Klaus Marschel files SEC Form 4 as officer at DCOY (Salarius Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter Klaus Marschel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | DCOY Salarius Pharmaceuticals, Inc. | AGrant or award Common Stock | +3,900 | $0.00 | $0 | 3,900 | 41 d ago |
Questions about Peter Klaus Marschel
Answered from the filings on this page, as of the latest one.
Is Peter Klaus Marschel buying or selling?
Peter Klaus Marschel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter Klaus Marschel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Klaus Marschel has 0.
Where does Peter Klaus Marschel file Form 4?
Peter Klaus Marschel has filed Form 4 at DCOY (Salarius Pharmaceuticals, Inc.) as Chief Business Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.